Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

FDA Drug Recalls

490 recalls · Class II, newest first

Class II · Moderate risk

Icosapent Ethyl Capsules

Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.

Ongoing Failed specification Zydus Pharmaceuticals (USA) Inc D-0400-2026

Recalls by year